Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-044019

Pres. & Chief Exec. Officer sold 4,172 shares at $20.66 ($86,194)

  • Pres. & Chief Exec. Officer acquired 550 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Option exercise 10b5-1 +550 $2.39 $1,315 22,029 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −550 $20.66 $11,363 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −1,357 $20.66 $28,036 42,067 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −1,153 $20.66 $23,821 35,755 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −278 $20.66 $5,743 12,646 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −278 $20.66 $5,743 12,646 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −278 $20.66 $5,743 12,646 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Sale 10b5-1 −278 $20.66 $5,743 12,646 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-06-15 Option exercise · Stock option (right to buy) 10b5-1 −550 91,881 D
Open-market sales · 4,172 sh · avg $20.66 · $86,194
Loading xslF345X06/wk-form4_1781732394.xml…